Given the compelling evidence that TST treatment reduces overall PD‐L1 protein levels in lung cancer cells in the presence of interferon‐gamma (IFNγ), we investigated the effect of TST on PD‐L1 enrichment in the cell membrane. This evidence concerns the gene IFNG and lung carcinoma.